In Vivo effect of Lidocaine on mouse exposed to Odontobuthos Doriae Scorpion venom
Journal Title: International Journal of Medical Research & Health Sciences (IJMRHS) - Year 2016, Vol 5, Issue 11
Abstract
Odontobuthos doriae, a native scorpion in southern tropical parts of Iran, can cause serious health threats and wide ranges of pharmacological disturbances. α-toxins in its venom cause prolongation of Na+ channels activity. In this study, reversing effects of lidocaine, as a Na+-channel blocker, was studied on mice following exposure to venom. Lidocaine (up to 500 mg/kg) and O. doriae crude venom (up to 12 µg/mice) was used in a 14-day acute toxicity test, to yield LD50s of 110mg/kg and 10µg/mice, respectively. Afterward, different sub-acute amounts of lidocaine (25%, 50% and 80% of LD50) were used in the presence of venom (80%, 100% and 120% of LD50). Our results show 80% LD50 of lidocaine, and not higher concentrations, could cause 50% reduction in lethality rate induced by O. doriae venom at LD50 concentration, showing the Na+-channel function in this event. Reducing the amount of lidocaine to safer doses show no significant effect in this aspect. Finally, lidocaine (80% LD50) can partially decrease the O. doriae venom mortality. However, due to some other systemic dangerous lidocaine adverse effects, it is doubtful that it can be a relevant life-saving agent in this case. Further to lidocaine failure in reversing the complete venom toxicity, it would be explained that high Na+ current induced by venom might prevent lidocaine effect at above doses, while higher concentrations also can cause lidocaine toxicity, which restricts our further investigation. Preferably, it would be suggested to use other medical approaches and medication to save the envenomed victim’s life.
Authors and Affiliations
Maryam Nakhjavani| Department of Toxicology and Pharmacology, School of Pharmacy, Shahid Beheshti Medical University, Tehran, Iran, Hossein Vatanpour| Department of Toxicology and Pharmacology, School of Pharmacy, Shahid Beheshti Medical University, Tehran, Iran, Akram Abootorabi| Department of Toxicology and Pharmacology, School of Pharmacy, Shahid Beheshti Medical University, Tehran, Iran, Fatemeh Shahriari| Department of Toxicology and Pharmacology, School of Pharmacy, Shahid Beheshti Medical University, Tehran, Iran, Baharak Mohamadzadehasl| Department of Toxicology and Pharmacology, School of Pharmacy, Shahid Beheshti Medical University, Tehran, Iran, Tannaz Bovand| Department of Pharmacology & Toxicology, Faculty of Pharmacy, Pharmaceutical Sciences Branch, Islamic Azad University, Tehran - Iran (IAUPS), Saba Vatanpour| Faculty of Sciences, University of British Columbia, BC, Canada, Corresponding E-mail: vatanpour.hossein@gmail.com
Keywords
Related Articles
- EP ID EP12167
- DOI -
- Views 290
- Downloads 13
Identifying Factors Influencing the Establishment of a Health System Reform Plan in Iran's Public Hospitals
In today's world, health views have found a wider perspective in which non-medical expectations are particularly catered to. The health system reform plan seeks to improve society's health, decrease treatment costs, and...
The effect of salvia officinalis tablet on hot flashes, night sweating, and estradiol hormone in postmenopausal women
Hot flashes and night sweats associated with menopause are the most annoying symptoms among premenopausal women and have been ranked as the first reason for referral to medical centers. The common treatment for this sy...
A RARE SHOULDER DISEASE OF PRIMARY SYNOVIAL CHONDROMATOSIS
Primary synovial chondromatosis is a rare, benign condition which affects the synovial membranes. It commonly involves knee, elbow and hip in young adults but is rare in shoulder. We reviewed a rare case of synovial ch...
EMERGING ROLE OF VITAMIN D IN HEALTH
Vit. D is a steroid prohormone. It is synthesized in the skin under ultra –violet light exposure. Traditionally, Vit.D3, cholecalciferol and calcitriol were known to have a role only in calcium and bone mineral metabo...
AGGRESSIVE ANGIOMYXOMA PRESENTING AS HUGE BROAD LIGAMENT TUMOR- A RARE CASE REPORT
Aggressive angiomyxoma was first described in 1983 by Steeper and Rosai, and fewer than 150 cases have been reported in the world medical literature. Aggressive angiomyxoma is a rare mesenchymal tumor occurring predomi...